TY - JOUR AU - Seied Asadollah Mousavi AU - Sorosh Rad AU - Tahereh Rostami AU - Mohammad Vaezi AU - Hosein Kamranzadeh AU - Davood Babakhani AU - Sahar Tavakoli AU - Maryam Barkhordar AU - Tanaz Bahri AU - Amirabbas Hedayatiasl AU - Azadeh Kiumarsi PY - 2020/07/01 Y2 - 2024/03/29 TI - Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Coronavirus Disease 2019 (COVID-19) Pandemic: An Iranian Consensus JF - Asian Pacific Journal of Cancer Care JA - apjcc VL - 5 IS - S1 SE - Original Research DO - 10.31557/apjcc.2020.5.S1.15-18 UR - http://www.waocp.com/journal/index.php/apjcc/article/view/391 AB - Background:COVID-19 has been declared as a public health emergency and a pandemic by World Health Organization. Among high-risk patients infected by the virus, hematopoietic stem cell transplant (HSCT) recipients are vulnerable to severe presentation of this infection. Thus, the necessity for precise strategies in dealing with HSCT recipients in this pandemic seems inevitable. Methods: We discussed the dilemmas brought up by the emergence of COVID-19 in the management of HSCT recipients, through a virtual panel of experts, considering the latest available records about COVID-19. About each enquiry, we have provided the consensus of the clinicians and paraclinicians in our center. Recommendations: We agreed to choose more precautious strategies and less optimal policies. The amendments aim to reduce the risk of exposure to COVID-19 in our patients and also in our health care provider team.  ER -